Ms Siobhán McArdle:

The policy itself is broad enough. I will give the example of the synthetic opioids. That change around naloxone and broadening the training role of the HSE is an example of how working with colleagues in the HSE and other agencies we use the broader lens of the policy to be able to adapt. The policy itself does not preclude us from being able to respond in a more agile way to that change in drugs at the moment.